期刊文献+

Observation on the effect of adefovir dipivoxil in combined with lamivudine in the treatment of hepatitis B cirrhosis

下载PDF
导出
摘要 Objective:To explore the effect of adefovir dipivoxil in combined with lamivudine on the liver function in patients with hepatitis B cirrhosis and the antiviral efficacy.Methods:A total of 156 patients with hepatitis B cirrhosis who were admitted in our hospital were included in the study and randomized into the treatment group and the control group with 78 cases in each group. The patients in the treatment group were given adefovir dipivoxil in combined with lamivudine, while the patients in the control group were given entecavir. After 12-month treatment, the efficacy was evaluated. The liver function, serum virology indicators, and AFP before and after treatment in the two groups were compared. The adverse reactions during the treatment process were recorded.Results: The serum GTP, ALT, AST, and TBIL levels after treatment in the two groups were significantly reduced when compared with before treatment (P<0.05);moreover, ALT and TBIL levels in the treatment group were significantly lower than those in the control group (P<0.05). HBeAg, HBV-DNA, and AFP levels after treatment in the two groups were significantly reduced when compared with before treatment (P<0.05), HBeAg and AFP levels in the treatment group were significantly lower than those in the control group (P<0.05), and the comparison of HBV-DNA between the two groups was not statistically significant (P>0.05). ALT normalization rate and HBeAg negative conversion rate after treatment in the treatment group were significantly higher than those in the control group (P<0.05). The comparison of HBV-DNA negative conversion rate and HBeAg conversion rate between the two groups was not statistically significant (P>0.05). No obvious drug adverse reactions and liver function damage occurred during the treatment process in the two groups. Conclusions:Adefovir dipivoxil in combined with lamivudine can significantly improve the liver function and serum virology indicators in patients with hepatitis B cirrhosis, with antiviral efficacy significantly superior to that by entecavir.
作者 Li Cui
出处 《Journal of Hainan Medical University》 2017年第5期13-16,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献3

二级参考文献25

  • 1张柏年,徐温理,孙伟建,杨伟中.颅内生殖细胞瘤综合治疗[J].中华神经外科杂志,1996,12(4):219-221. 被引量:8
  • 2庄辉.乙型肝炎流行病学研究进展[J].国外医学(流行病学.传染病学分册),2004,31(3):133-135. 被引量:149
  • 3REHERMANN B. Intrahepatic T cells in hepatitis B viral control versus liver cell injury[J]. Exp Med, 2000, 191(8): 1263-1268.
  • 4BERTOLETTI A, FERRARI C. Kinetics of the immune response during HBV and HCV infection[J]. Hepatology, 2003, 38(1): 4-13.
  • 5XIBING G, XIAOJUAN Y, ZHONGHUA L, et al. Alteration in cellular immunity after chronic hepatitis b deteriorated into se- vere hepatitis and its significance[J]. Hepat Man, 2011, 11(10): 810-815.
  • 6FLYNN K, MULLBACHER A. The generation of memory anti- gen-specific cytotoxic T cell responses by CD28/CD80 interac- tions in the absence of antigen[J]. Eur J Immunol, 1997, 27(2): 456-462.
  • 7CHEN L. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity[J]. Nat Rer Immunol, 2004, 4(5): 336- 347.
  • 8OKAZAKI T, HONJO T. The PD-1-PD-L pathway in immuno- logical tolerance[J]. Trends Immunol, 2006, 27(4): 195-201.
  • 9ZHANG JY, ZHANG Z, WANG X, et al. PD-1 up-regulationis correlated with HIV- specific memory CDS+ T-cell exhau: tion in typical progressors but not in long-term nonprogressc [J]. Blood, 2007, 109(11): 4671-4678.
  • 10GOLDEN-MASON L, PALMER B, KLARQUIST J, et al. Up- regulation of PD-1 expression on circulating and intrahepatic hepatitis C Virus-specific CD8+ T cells associated with re- versible immune dysfunction[J]. J Viral, 2007, 81(17): 9249-9258.

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部